Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    20825986 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type
Conditions: EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT;   CHROMOSOME 2q31.2 DELETION SYNDROME
Interventions: Drug: celiprolol;   Drug: Control
2 Recruiting Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome (ARCADE)
Condition: Ehlers-Danlos Syndrome, Vascular Type
Interventions: Drug: Irbesartan;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.